Companies / Spruce Biosciences, Inc.
Spruce Biosciences, Inc.
Nasdaq: SPRBCIK 1683553SOUTH SAN FRANCISCO, CA
Financials · FY2025
Ownership
2.9M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 0.66% | 19,004 |
| 10%+ / strategic | 2.15% | 61,670 |
| Institutions | 44.87% | 1,289,506 |
| Public float | 52.33% | 1,503,833 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 5
View all →| Insider | % of shares | Shares |
|---|---|---|
Szwarcberg Javier B.CEOCHIEF EXECUTIVE OFFICER · Director | 0.66% | 19,004 |
Ways Douglas KirkFormerInterim Chief Medical Officer · Director | 0.04% | 1,250 |
Grey Michael GExecutive Chairman · Director | — | — |
Hooks Corwin DaleFormerChief Commercial Officer | — | — |
Spiegelman Daniel KDirector | — | — |
Institutional holders 36
View all →| Holder | Value | % of shares |
|---|---|---|
| $13.50M | 8.70% | |
| $10.57M | 4.22% | |
| $10.14M | 6.54% | |
| $7.31M | 3.89% | |
| $6.10M | 2.44% | |
| $6.10M | 2.44% | |
| $5.14M | 2.05% | |
| $5.05M | 2.02% | |
| $4.50M | 1.80% | |
| $4.18M | 1.67% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q2 2026 as of | AIGH Capital Management LLC 13F manager | New | Common Stock | $13.50M | +250K | 250,000 8.70% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common Stock | $9.23M | +171K +1008.96% | 187,836 6.54% of shares | medium |
| Q1 2026 as of | Millennium Management LLC 13F manager | New | Common Stock | $7.31M | +112K | 111,888 3.89% of shares | medium |
| Q2 2026 as of | State Street Corporation 13F manager | Add | Common Stock | $2.38M | +44K +688.28% | 50,450 1.76% of shares | low |
| Q2 2026 as of | Persistent Asset Partners Ltd 13F manager | New | Common Stock | $414.6K | +8K | 7,677 0.27% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Exit | Common Stock | $-174.2K | -2K -100.00% | — | low |
| Q2 2026 as of | Deutsche Bank AG 13F manager | New | Common Stock | $143.2K | +3K | 2,652 0.09% of shares | low |
| Q1 2026 as of | Geode Capital Management, LLC 13F manager | Add | Common Stock | $10.3K | +157 +1.23% | 12,889 0.45% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Integrated Core Strategies (US) LLC | Passive13G | — |
| Citadel Advisors LLC | Passive13G/A | — |
| Alyeska Investment Group, L.P. | Passive13G | — |
| Squadron Master Fund LP | Passive13G/A | — |
| Wellington Management Group LLP | Passive13G | — |
| ADAR1 Capital Management, LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| SPRB | Common Stock | 85209E208 |